Polyanions are potent HIV-1 entry inhibitors. Nevertheless, resistant viruses may emerge under polyanion inhibitory pressure. Specifically, a polyanion-resistant virus replicates in T cells even in the presence of high concentrations of polyanions. We found that although the polyanion-resistant virus grows in suspension CD4+ T cells efficiently, it infects nonlymphocytic adherent CD4+ cells poorly. Given that a main distinction between suspension and adherent cells is the absence or presence of cell-surface heparan sulfate proteoglycan (HSPG), we investigated if the failure of the polyanion-resistant virus to infect adherent CD4+ cells arises from its inability to bind HSPG. We found that the emergence of mutations in gp120 associated with polyanion resistance resulted in a decreased capacity of HIV-1 to bind HSPG. We also found that the polycation polybrene rescued the capacity of the polyanion-resistant virus to bind HSPG and to infect adherent CD4+ cells. The identification of this virus, unable to bind HSPG, provides a convenient probe to measure the impact of HIV-1 -HSPG interactions in vivo. Altogether, these findings suggest that polyanion-resistance narrows the range of potential target cells for HIV-1 in the host. This reinforces the hypothesis that cell-free or cell-associated polyanions such as HSPG possess the capacity to modulate HIV-1 pathogenesis. D
Introduction
Dextran sulfate (DS) exerts an inhibitory effect against HIV-1 as well as HIV-2 by blocking viral entry (Baba et al., 1988; Ito et al., 1987; Mitsuya et al., 1988; Ueno and Kuno, 1987) . Gp120 represents the main binding target for DS (Callahan et al., 1991; Mbemba et al., 1992; Schols et al., 1990) . Because DS prevents the recognition of gp120 by anti-V3 loop antibodies, it strongly suggests that the hypervariable V3 loop of gp120 represents a main locus for DS binding (Callahan et al., 1991; Harrop et al., 1994; Moulard et al., 2000; Okada et al., 1995) . The observations that DS does not interfere with gp120-CD4 interactions (Callahan et al., 1991; Mbemba et al., 1992; Moulard et al., 2000) , but interferes with gp120 -coreceptor interactions (at least CXCR4) (Moulard et al., 2000) , are in accordance with the assumption that the V3 loop serves a main point of contact between gp120 and the coreceptors CXCR4 and CCR5 . Several lines of evidence underline the importance of electrostatic interactions between positively charged (basic) residues in both the V3 loop and the conserved coreceptor binding domain of gp120 with negatively charged (acidic or sulfated) residues located in the extracellular domain of the coreceptor (Basmaciogullari et al., 2002; Dragic et al., 1998; Farzan et al., 1998 Farzan et al., , 1999 Hatse et al., 2001; Rabut et al., 1998; Wang et al., 1998 Wang et al., , 1999 . Thus, likely, the direct binding of the negatively charged polyanion DS to the V3 loop or the conserved coreceptor binding domains interferes with gp120 -coreceptor interactions, and therefore prevents efficient HIV-1 fusion and entry.
Previous studies showed that a virus resistant to both polyanions-DS and the G-quartet forming oligonucleotide AR177-can be selected in vitro (Este et al., 1997 (Este et al., , 1998 . Specifically, the X4 NL4.3 HIV-1 strain was grown in suspension CD4+ MT-4 cells in the presence of increasing concentrations of the above polyanions. The virus recovered was able to replicate in MT-4 cells even in the presence of high concentrations of polyanions, whereas wild-type NL4.3 was unable to replicate under these conditions. The finding that mutations mainly arose in the gp120 of the polyanion-resistant virus (Fig. 1A) (de Vreese et al., 1996) strongly suggests that resistance of HIV-1 to polyanions is associated with mutations in gp120.
DS resembles the large family of glycosaminoglycans (GAG) that includes dermatan sulfate, keratan sulfate, heparan sulfate, and chondroitin sulfate (Bernfield et al., 1999) . All these polyanions are capable of modulating HIV-1 infection. Although a majority of soluble GAG in general exhibits an inhibitory effect on HIV-1 infection (at least for X4 viruses) (Baba et al., 1988; Bagasra et al., 1991; Callahan et al., 1991; Mitsuya et al., 1988; Patel et al., 1993) , cellsurface-associated GAG (such as heparan sulfate or chondroitin sulfate) in some circumstances exert beneficial effects on HIV-1 replication. Originally, Norcross et al. demonstrated that cell-surface heparan sulfates promote HIV-1 infection in several cell lines (Patel et al., 1993; Roderiquez et al., 1995) . Several groups confirmed these results by showing that the presence of heparan sulfate proteoglycan (HSPG) on the surface of specific cell types may greatly influence HIV-1 infection (Guibinga et al., 2002; Mondor et al., 1998; Ohshiro et al., 1996; Saphire et al., 2001; Zhang et al., 2002) . Specifically, Zhang et al. using a large panel of primary viruses (envelopes) nicely showed that the presence of cell-surface GAG may either facilitate HIV-1 infectivity (i.e. X4 viruses) or diminish HIV-1 infectivity (i.e., R5 viruses). Thus, cell-surface GAG possesses the capacity to exert either a detrimental or beneficial effect on HIV-1 infection. More recently, we found that HSPG, especially syndecans, expressed on the surface of the human endothelium may capture HIV-1 particles, protect them for several days, and present and transfer them to trafficking T cells that become ultimately infected (Bobardt et al., 2003) . Furthermore, we and others presented evidence that heparan and chondroitin sulfates expressed on the surface of brain microvascular endothelial cells may facilitate HIV-1 transcytosis through the blood -brain barrier (Argyris et al., 2003; Bobardt et al., 2004; Liu et al., 2002) . Altogether, these observations suggest that although soluble GAG present in the blood likely inhibits HIV-1 infection (at least X4 viruses), cell-surface GAG abundantly expressed on specific cells and tissues may facilitate HIV-1 pathogenesis. Therefore, the capacity of gp120 to bind soluble or cell-associated GAG may be either beneficial or detrimental for HIV-1 depending on the microenvironment. The polyanion-resistant virus replicates at wild-type levels in T-cell lines even in the presence of inhibitory polyanion concentrations. Jurkat or MT-4 cells (0.5 Â 10 6 cells) were exposed to 2 ng of p24 of wild-type or polyanion-resistant NL4.3 viruses (derived from MT-4 cells) for 2 h and washed to remove unbound virus. Dextran sulfate (5000 Da) was added at concentration of 10 Ag/ml. Viral replication was measured by p24 ELISA every 3 days. Results are representative of two independent experiments.
In the present study, we analyzed the capacity of a polyanion-resistant virus to attach to the surface of target cells via GAG, and to replicate in CD4+ cells that express or lack GAG. We found that although the polyanion-resistant virus grows perfectly in suspension T-cell lines such as Jurkat and MT-4 cells that lack GAG, it poorly infects adherent target cells that express GAG such as CD4+ HeLa or GHOST cells. Given that previous studies suggested that GAG, specifically HSPG, facilitate HIV-1 infection in specific target cells, we asked if the inability of the polyanion-resistant virus to infect CD4+ HeLa and GHOST cells correlates with a failure to bind to HSPG. We found that in contrast to wild-type virus, the polyanion-resistant virus fails to efficiently bind to HSPG. Furthermore, we observed that the polycation-polybrene-rescues the capacity of the polyanion-resistant virus to either bind HSPG or to infect CD4+ HeLa and GHOST cells. Our results suggest that polyanion resistance narrows the range of potential target cells for HIV-1 in the host, and further support the notion that cell-free or cell-associated polyanions such as HSPG possess the capacity to modulate HIV-1 pathogenesis.
Results

Polyanion-resistant HIV-1 efficiently replicates in suspension CD4+ T cells
We first examined the resistance of the polyanion-resistant NL4.3 virus to DS using suspension CD4+ Jurkat T cells as well as CD4+ MT-4 cells ( Fig. 1B) . Wild-type and polyanion-resistant NL4.3 viruses were added to T cells together with or without 10 Ag/ml of DS. Twenty-four hours post-infection, cells were washed twice to remove the initial inoculum and incubated in fresh medium containing 10 Ag/ ml of DS. Viral replication was monitored every 3 days by measuring amounts of capsid released into the medium by p24 ELISA. We found that DS drastically reduces the growth of wild-type NL4.3 in both Jurkat and MT-4 cells ( Fig. 1B) , confirming the efficacious inhibitory effect of the soluble polyanion. In sharp contrast, we observed that the growth of the polyanion-resistant NL4.3 was not significantly altered by the presence of the polyanion compared to wild-type growth in the absence of DS ( Fig. 1B ). We obtained similar results using other T-cell lines including MOLT and HUT-78 (data not shown). This demonstrates that the polyanion-resistant virus is perfectly capable to resist the inhibitory pressure of DS in several T-cell lines (Este et al., 1998) .
Polyanion-resistant HIV-1 infects adherent CD4+ cells poorly
After demonstrating that the polyanion-resistant NL4.3 grows at wild-type levels in several suspension CD4+ T-cell lines, we asked if its resistance to DS extends to non-lymphocytic targets such as adherent CD4+ cells. The major adherent target cell for HIV-1 in vivo is the macrophage. Unfortunately, NL4.3 (X4 virus) cannot infect primary macrophages. Thus, we examined the infectivity of the polyanion-resistant NL4.3 in adherent CD4+ cells that are permissive to NL4.3 such as epithelial CD4+ CXCR4+ HeLa cells (called TZM-bl) and osteosarcoma CD4+ CXCR4+ cells (called GHOST). To measure HIV-1 infectivity, we took advantage of the fact that TZM-bl cells contain h-galactosidase and luciferase reporter genes (Wei et al., 2002) , whereas GHOST cells contain a GFP reporter gene (Morner et al., 1999) . Adherent TZM-bl and GHOST cells were exposed to wild-type and polyanion-resistant NL4.3 viruses for 24 h, washed twice to remove viral inoculum, and incubated at 37 jC for 48 h. To measure infectivity, TZM-bl cells were stained with Xgal and number of blue foci counted, whereas GHOST cells were analyzed for GFP content by FACS. Interestingly, we found that although the polyanion-resistant NL4.3 is perfectly able to infect T-cell lines ( Fig. 1) , it poorly infects both adherent CD4+ HeLa or GHOST cells compared to wild-type virus (about 12-fold decrease) ( Fig. 2) . As above, DS does not affect the infectivity of the polyanion-resistant NL4.3 virus in both TZM-bl and GHOST cells (data not shown). This strongly suggests that the resistance to polyanions is target cell specific.
Suspension and adherent CD4+ cells express opposite levels of HSPG and CD4
To understand this difference in susceptibility to the polyanion-resistant NL4.3 virus, Jurkat, MT-4, CD4+ HeLa, and GHOST cells were analyzed for their surface expression of several receptors known to influence HIV-1 attachment or fusion such as DC-SIGN/R, HSPG, CD4, and CXCR4. First, we found that all four cell lines express considerable levels of CXCR4 and no detectable levels of DC-SIGN/R ( Fig. 3) . Although the four cell lines express significant levels of CD4, the two T-cell lines, Jurkat and MT-4, express higher CD4 levels than the two nonlymphocytic cell lines, TZM-bl and GHOST. Furthermore, we found that Jurkat and MT-4 cells express almost undetectable levels of HSPG, whereas TZM-bl and GHOST cells richly express HSPG (Fig. 3 ). Our observation that polyanion-resistant NL4.3 ''permissive'' cells (Jurkat and MT-4) express low HSPG and high CD4 levels, whereas ''nonpermissive'' cells (TZM-bl and GHOST) express high HSPG but low CD4 levels, suggests a correlation between refractivity of target cells to polyanion-resistant NL4.3 and the cell-surface expression of CD4 and HSPG.
Polyanion-resistant HIV-1 fails to bind to cell-surface HSPG
To escape polyanion selective pressure, HIV-1 developed mutations in gp120. We postulated that the polyanion-resistant NL4.3 virus would not bind to polyanions such as HSPG. The major members of the HSPG family are the syndecans (Bernfield et al., 1999) . Syndecans are transmembrane proteins with an ectodomain that bears three anionic heparan sulfate chains (Bernfield et al., 1999) . There are four syndecan members that all possess the capacity to bind HIV-1 (Bobardt et al., 2003 , Saphire et al., 2001 . We compared the capacity of the polyanion-resistant NL4.3 virus to bind cell-surface syndecans with that of wild-type NL4.3. Parental CD4-negative Namalwa B cells, syndecantransfected cells (Namalwa B cells stably transfected with human syndecan-2), and DC-SIGN-transfected cells (Namalwa B cells stably transfected with human DC-SIGN) were exposed to wild-type or polyanion-resistant NL4.3 viruses for 2 h at 37 jC as described previously (Bobardt et al., 2003) . Cell-surface expression of syndecan-2 and DC-SIGN was verified before the attachment assay as described previously (Bobardt et al., 2003) . Cells were then washed and lysed. Amounts of bound virus were determined by measuring HIV-1 capsid content in cell lysate by p24 ELISA. No capsid internalization occurs under these con-ditions (data not shown). Although no binding was observed with parental cells, wild-type and polyanion-resistant NL4.3 viruses bind equivalently well to DC-SIGN+ cells (Fig. 4A ). In sharp contrast, the polyanion-resistant NL4.3 virus binds poorly to syndecan+ cells compared to wild-type virus. One explanation for this failure to bind HSPG is that the polyanion-resistant NL4.3 virus contains less gp120 than wild-type virus. Thus, we compared the amounts of gp120 incorporated into wild-type and polyanion-resistant NL4.3 viruses. We found that both viruses packaged similar amounts of gp120 ( Fig. 4B ) eliminating this parameter to explain the difference in syndecan binding between the two viruses. The observation that both viruses bind equivalently well to DC-SIGN further supports the notion that they contain similar levels of gp120.
Polybrene rescues polyanion-resistant HIV-1 binding to HSPG and infectivity of adherent CD4+ cells
We showed that in contrast to wild-type NL4.3, the polyanion-resistant NL4.3 virus had reduced binding to cell-surface HSPG. Given that the polyanion-resistant NL4.3 virus poorly infects cells that express low CD4 but high HSPG levels such as TZM-bl and GHOST, we postulated that this failure arises from the inability of the polyanion-resistant NL4.3 virus to bind these cells via HSPG. Previous studies suggested that cell-surface HSPG exert their positive effect on HIV-1 infection by simply promoting the initial viral adsorption onto the surface of specific cell types (Mondor et al., 1998; Patel et al., 1993; Roderiquez et al., 1995; Saphire et al., 2001) . In this scenario, more infectious particles accumulate at the surface of the target cell favoring the encounter between the virus and the entry receptors-CD4 and the coreceptors. Thus, if the polyanionresistant NL4.3 virus poorly infects TZM-bl and GHOST cells simply due to a failure to attach via HSPG, one can imagine that by forcing or promoting the initial viral adsorption, this would rescue its infectivity. Given that previous work showed that the polycation polybrene promotes HIV-1 attachment to the surface of target cells (O'Doherty et al., 2000) , we asked if polybrene by enhancing the polyanion-resistant NL4.3 virus attachment would rescue its infectivity in TZM-bl and GHOST cells. We first examined if polybrene restores the polyanion-resistant NL4.3 virus binding to HSPG. We found that the presence of polybrene does not alter the capacities of wild-type and polyanion-resistant NL4.3 viruses to bind to DC-SIGN+ or parental cells that lack HSPG (data not shown). Interestingly, although polybrene (10 Ag/ml) slightly enhanced wildtype binding, it strongly promoted the binding of the polyanion-resistant NL4.3 virus to cell-surface syndecans (Fig. 5A ). This suggests that the presence of the polycation totally rescues the capacity of the polyanion-resistant NL4.3 virus to bind to HSPG. After identifying conditions that restore the attachment of the polyanion-resistant NL4.3 virus to HSPG, we examined the effect of increasing concentrations of polybrene on the infectivity of the polyanion-resistant NL4.3 virus in TZM-bl cells. Importantly, we found that although wild-type infectivity was slightly enhanced, the polybrene dramatically enhanced the infec- Fig. 5 . Polybrene rescues polyanion-resistant virus capacities to bind to cell-surface HSPG and to infect CD4+ adherent cells. (A) Syndecan-2+ Namalwa B cells (0.25 Â 10 6 cells) were exposed to wild-type and polyanion-resistant NL4.3 viruses (derived from MT-4 cells) (1 ng of p24) for 2 h at 37 jC in the presence of increasing concentrations of polybrene, washed, and lysed, and p24 content was measured by ELISA. Results (duplicates) are expressed in percentage of p24 captured relative to the initial inoculum. This experiment is representative of two independent experiments. (B) TZM-bl (0.25 Â 10 6 cells) cells were exposed to 2 ng of p24 for 2 h in the presence or absence of polybrene and washed to remove unbound virus, and viral infection was measured 48 h post-infection by Xgal staining. Values (duplicates) are expressed in number of blue foci per ng of p24. Fig. 4 . The polyanion-resistant virus lost its capacity to bind to cell-surface HSPG. (A) Parental Namalwa B cells, syndecan-2+ cells, and DC-SIGN+ cells (0.25 Â 10 6 cells) were exposed to wild-type or polyanion-resistant NL4.3 viruses (derived from MT-4 cells) (1 ng of p24) for 2 h at 37 jC, washed, and lysed, and p24 content was measured by ELISA. Results (duplicates) are expressed in percentage of p24 captured relative to the initial inoculum. This experiment is representative of two independent experiments. (B) Amounts of gp120 of wild-type, polyanion-resistant and gp160-deficient NL4.3 viruses (2 ng of p24) were measured by ELISA. Values (triplicates) are expressed in pg of gp120 per ng of p24. Results are representative of two independent experiments. tivity of the polyanion-resistant NL4.3 virus (Fig. 5B) . Note that at the highest concentration (20 Ag/ml), polybrene exerts an inhibitory effect on wild-type infectivity (data not shown). We obtained similar results using GHOST cells as targets (data not shown). Importantly, polybrene (1-10 Ag/ml) has no major effect on wild-type and polyanionresistant NL4.3 virus replication in the two CD4+ T-cell lines, MT-4 and Jurkat, which express low HSPG but high CD4 levels (data not shown). Thus, our data indicate that there is a direct correlation between the incapacity of the polyanion-resistant NL4.3 virus to bind to HSPG and its incapacity to efficiently infect adherent CD4+ target cells.
The presence of HSPG on adherent target cells does not represent an obstacle for polyanion-resistant HIV-1 infection
We showed that the polyanion-resistant NL4.3 virus fails to efficiently infect adherent cells, which express high HSPG levels, such as TZM-bl and GHOST cells (Fig. 3) . One simple explanation is that cell-surface HSPG exert a detrimental effect on polyanion-resistant NL4.3 virus entry into CD4+ adherent cells. To address this issue, both suspension (MT-4) and adherent (TZM-bl) target cells were pretreated with heparinase to remove cell-surface heparan sulfate moieties as described previously (Saphire et al., 2001) . The removal of cell-surface HSPG was verified by FACS (80% removed) (Fig. 3) . As expected, we found that the removal of HSPG from the surface of T cells does not affect the replication of wild-type and polyanion-resistant NL4.3 viruses (Fig. 6A) . By contrast, wild-type infectivity was reduced in CD4+ adherent cells after HSPG removal (Fig. 6B ), suggesting that HSPG on the surface of TZM-bl facilitates NL4.3 infection, likely by promoting viral adsorption as previously suggested (Mondor et al., 1998; Saphire et al., 2001) . Note that chondroitinase treatment that removes another class of GAG-chondroitin sulfate proteoglycans-does not influence HIV-1 infection as previously reported (data not shown; Mondor et al., 1998; Saphire et al., 2001) . However, the removal of HSPG on TZM-bl cells did not rescue the infectivity of the polyanion-resistant NL4.3 virus, indicating that the presence of cell-surface HSPG is not detrimental to the infectivity of the resistant mutant virus in CD4+ adherent cells. Note that we obtained similar results using Jurkat and GHOST cells (data not shown). Fig. 6 . The removal of HSPG from CD4+ adherent cells does not rescue the infectivity of the polyanion-resistant virus. (A) MT-4 cells (0.5 Â 10 6 cells) pretreated or not with heparinase (10U) were exposed to 2 ng of p24 of wild-type or polyanion-resistant NL4.3 viruses (derived from MT-4 cells) for 2 h and washed to remove unbound virus. Viral replication was measured by p24 ELISA every 3 days. Results are representative of two independent experiments. (B) TZM-bl (0.25 Â 10 6 cells) cells pretreated or not with heparinase (10U) were exposed to 2 ng of p24 for 2 h and washed to remove unbound virus, and viral infection was measured 48 h post-infection by Xgal staining. Results are representative of two independent experiments.
Discussion
In the present study, we showed that although a polyanion-resistant virus perfectly replicates in several T-cell lines, it exhibits reduced infectivity in adherent nonlymphocytic CD4+ cell targets such as TZM-bl and GHOST cells. This finding strongly suggests that the apparent robustness of the polyanion-resistant virus strictly depends on the type of target cells used. We asked why the polyanion-resistant virus is unable to efficiently infect TZM-bl and GHOST cells. We found that ''nonpermissive'' adherent TZM-bl and GHOST cells express high HSPG but low CD4 levels, whereas ''permissive'' MT-4 and Jurkat cells express low HSPG but high CD4 levels, suggesting a correlation between HSPG and CD4 expression and the permissivity of the target cells to the polyanion-resistant virus. We then postulated that HIV-1, to rapidly evade the polyanion selective pressure, mutated its glycoprotein in a way that gp120 is no longer recognized by polyanions. Corroborating this hypothesis, we found that the polyanion-resistant virus fails to bind HSPG. We also showed that the presence of polybrene, an agent that forces HIV-1 attachment onto the surface of target cells, restores the capacity of the polyanion-resistant virus to bind HSPG. Polybrene also rescues the infectivity of the polyanion-resistant virus in TZM-bl and GHOST cells. Altogether, our data strongly suggest that the resistance to polyanions somewhat altered the gp120 of the polyanion-resistant virus in a manner that preserves its capacity to infect T cells, but diminishes its capacity to infect adherent CD4+ cells.
A question that arises from these findings is why is the polyanion-resistant virus capable of infecting suspension CD4+ cells but unable to infect adherent CD4+ target cells? Because we showed that the polyanion-resistant virus cannot bind to HSPG, the simplest scenario to explain its failure to infect CD4+ adherent cells is that HSPG serve as attachment receptors. The low amounts of CD4 on TZMbl and GHOST might be insufficient to mediate the initial adsorption of the virus, and ancillary interactions, such as HSPG -gp120 interactions, are necessary for successful attachment and viral entry. Supporting this hypothesis, polybrene rescued the infectivity of the polyanion-resistant virus into TZM-bl and GHOST cells. Alternatively, the mutations in gp120 that confer resistance to polyanions subtly diminish the affinity of gp120 to CD4. In this scenario, the low CD4 levels on TZM-bl and GHOST cells would magnify this deficit, whereas on T cells, the high CD4 levels would mask this handicap. Lastly, we cannot rule out the possibility that HSPG do not serve as attachment receptors, rather they favor CD4 -gp120 -coreceptor interactions necessary for successful fusion. Because HSPG bind the V3 loop of gp120, they also may modulate gp120coreceptor interactions by altering electrostatic contacts between the positive charges of V3 loop and the coreceptor-binding domain of gp120 and the negative charges of the extracellular domain of the coreceptor.
The inability of polyanion-resistant viruses to infect adherent CD4+ cells may not represent a major obstacle for X4 viruses given that with the exception of macrophages, no adherent CD4+ cells exist in humans. By contrast, the incapacity of R5 viruses to infect macrophages due to polyanion resistance may have profound effect on HIV-1 pathogenesis. It would be interesting to select polyanion-resistant R5 viruses and to examine the capacities of emerging mutant viruses to infect macrophages. Nevertheless, it is important to note that in terms of CD4 levels, HSPG levels and contribution of HSPG to HIV-1 infection, we observed similar behavior between primary human macrophages, TZM-bl, and GHOST cells (Saphire et al., 2001) .
Several studies showed that R5 viruses are more resistant against the inhibitory effect of polyanions than X4 viruses (Meylan et al., 1994; Moulard et al., 2000; . In this model, the highly positive charged V3 loop of X4, in contrast to the low positive charged V3 loop of R5 virus, represents an ideal ligand for polyanions, resulting in a strong interference with gp120 -CXCR4 interactions. Another scenario that would explain why R5 viruses are less sensitive to polyanion inhibition is simply that their fusion capacity is superior to that of X4 viruses. Supporting this hypothesis, R5 viruses are 10-fold more resistant to the fusion inhibitory peptide T-20 than X4 viruses (Derdeyn et al., 2001; Xu et al., 2000) . If R5 viruses truly fuse more rapidly than X4 viruses, this would lessen the chance of polyanions to exert its inhibitory action on R5 infection. Note that the original observation by Meylan et al. (1994) , that the infectivity of R5 viruses is not diminished (rather enhanced) by polyanions, was exclusively observed using macrophages as targets. Indeed, polyanions blocked R5 virus infectivity in PBMCs (Meylan et al., 1994) . Given that macrophages, in contrast to PBMCs, express high HSPG levels (Saphire et al., 2001) , this suggests that the inhibitory effect of polyanions on HIV-1 infection is reduced when target cells express HSPG. This further suggests that HIV-1 sensitivity to polyanions is not simply V3 loop charge specific, but also target cell type specific.
Although the polyanion-resistant virus still replicates in T-lymphocytes, its inability to bind HSPG may exert a detrimental effect on the progress of pathogenesis. For example, HSPG on the surface of the genital epithelium may promote HIV-1 sexual transmission, HSPG on the surface of macrophages may facilitate the establishment of long-term viral reservoirs (Saphire et al., 2001) , and HSPG by capturing and protecting HIV-1 for several days onto the surface of the endothelium (Bobardt et al., 2003) may facilitate the escape of the virus toward the immune response. Furthermore, we and others presented several lines of evidence that proteoglycans on the surface of the blood -brain barrier may facilitate the invasion of HIV-1 into the brain (Argyris et al., 2003; Bobardt et al., 2004; Liu et al., 2002) . Therefore, the identification of a mutant virus unable to bind HSPG, such as the polyanion-resistant virus examined in this study, provides a convenient probe to measure the impact of HIV-1 -HSPG interactions in vivo. To our knowledge, this is the first description of a virus that displays such a disparate infectivity with respect to target cell type.
Material and methods
Cells
Human Jurkat T cells (generously contributed by ATCC and Dr. Arthur Weiss), MT-4 T cells (generously contributed by Dr. Douglas Richman), CD4+ CXCR4+ GHOST cells (CD4+ osteosarcoma cells) (generously contributed by Dr. Vineet KewalRamani and Dr. Dan Littman), and TZMbl (CD4+ HeLa cells) (generously contributed by Dr. John C. Kappes, Dr. Xiaoyun Wu, and Tranzyme Inc.) were obtained through the AIDS Research and Reference Reagent Program. Parental Namalwa B cells, syndecan-2transfected Namalwa cells, and DC-SIGN-transfected Namalwa cells were generated as described previously (Bobardt et al., 2003) .
FACS analyses
One million cells were incubated with antibodies (1 Ag) in 500 Al of PBS containing 0.25% human serum. Anti-CD4 mAb SIM.4 (generously contributed by Dr. James Hildreth), anti-DC-SIGN mAb DC28 (generously contributed by Drs. F. Baribaud, S. Pohlmann, J.A. Hoxie, and R.W. Doms), and anti-CXCR4 mAb 12G5 (generously contributed by Dr. James Hoxie) were obtained through the AIDS Research and Reference Reagent Program. Anti-HSPG mAb 10E4 was obtained from Seikagaku. Adherent TZM-bl and GHOST cells were detached with Cell Striper (Mediatech Inc.).
Infections
The polyanion-resistant virus (NL4.3-derived) was generated by Este et al. (1997) as previously described. Viral load was standardized by p24 antigen by ELISA (Perkin Elmer Life Sciences). Jurkat and MT-4 cells (0.5 Â 10 6 cells) were exposed to 2 ng of p24 for 2 h and washed to remove unbound virus, and viral replication was measured by p24 ELISA every 3 days. TZM-bl and GHOST cells were exposed to 2 ng of p24 for 2 h and washed to remove unbound virus, and viral infection was measured 48 h postinfection by h-galactosidase (Xgal staining) for TZM-bl cells and by GFP (FACS) content for GHOST cells. Dextran sulfate 5000 Da (Sigma) was used at concentration from 1 to 10 Ag/ml. Heparinase (10 U) (Sigma) treatment (2 h at 37 jC) was performed as described previously (Saphire et al., 2001) .
Attachment assay
Virus binding assay was performed as described previously (Bobardt et al., 2003; Pohlmann et al., 2001) . In brief, Namalwa cells (0.25 Â 10 6 cells/500 Al complete RPMI) were exposed to NL4.3 (1 ng of p24) for 2 h at 37 jC, washed three times with 3 ml of PBS, lysed in Triton X-100, and p24 content in cell lysate was measured by ELISA (Perkin Elmer Life Sciences).
Gp120 ELISA ELISA (96-well) plates (Immulon, Thermo Labsystem) were coated overnight at 37 jC with recombinant human anti-gp120 2G12 IgG (2 Ag/ml in PBS) (generously contributed by Dr. Hermann Katinger) obtained through the AIDS Research and Reference Reagent Program. Plates were washed twice with PBS, blocked for 1 h at 37 jC in 5% FCS in PBS, and washed four times with 0.2% Tween 20 in PBS. Lysed viruses (samples diluted in 10% FCS, 0.5% TX100 in PBS) or recombinant gp120 (standard curve from 0 to 10 ng/ml) (obtained through the AIDS Research and Reference Reagent Program and generously contributed by DAIDS and NIAID) were added to the plates for 2 h at 37 jC. Plates were washed four times with 0.2% Tween 20 in PBS. Rabbit polyclonal anti-gp120 serum (Intracel) was added to the plates at a dilution of 1/5000 in 10% FCS, 0.5% TX100 in PBS for 1 h at 37 jC. Plates were washed four times with 0.2% Tween 20 in PBS. Anti-rabbit-HRP (Pierce) was added to the plates at a dilution of 1/5000 in 10% FCS, 0.5% TX100 in PBS for 1 h at 37 jC. Plates were washed four times with 0.2% Tween 20 in PBS. After adding the substrate for 30 min at room temperature, the reaction was stopped with 4 N H 2 SO 4 . Plates were read at 450 nm with a reference at 650 nm.
